TICKERNOMICS Sign up
Last Update: 2023-12-23 05:57:50
ILLUMINA INC. ( ILMN ) https://www.illumina.com
140.23USD
Sector:
Healthcare
Industry:
Diagnostics & Research
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-26.67%
ILMN
SPY
30.72%
-61.74%
ILMN
SPY
112.82%
-48.53%
ILMN
SPY
201.04%
ILMN
29.70%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
20081.80
24449.80
2.53
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-17.85
4.42
3.40
-0.84
0.00
-31.67
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-67.38
61.13
-17.29
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.9936
-13.37
-14.05
1.24
Other Earnings and Cash Flow Stats:
ILLUMINA INC. ( ILMN ) Net Income TTM ($MM) is -1125.00
ILLUMINA INC. ( ILMN ) Operating Income TTM ($MM) is -1033.00
ILLUMINA INC. ( ILMN ) Owners' Earnings Annual ($MM) is 0.00
ILLUMINA INC. ( ILMN ) Current Price to Owners' Earnings ratio is 0.00
ILLUMINA INC. ( ILMN ) EBITDA TTM ($MM) is -772.00
ILLUMINA INC. ( ILMN ) EBITDA Margin is -17.29%
Capital Allocation:
ILLUMINA INC. ( ILMN ) has paid 0.00 dividends per share and bought back -1.0 million shares in the past 12 months
ILLUMINA INC. ( ILMN ) has increased its debt by 562.0 million USD in the last 12 months
Capital Structure:
ILLUMINA INC. ( ILMN ) Interest-bearing Debt ($MM) as of last quarter is 4374
ILLUMINA INC. ( ILMN ) Annual Working Capital Investments ($MM) are 685
ILLUMINA INC. ( ILMN ) Book Value ($MM) as of last quarter is 5898
ILLUMINA INC. ( ILMN ) Debt/Capital as of last quarter is 74%
Other Balance Sheet Stats:
ILLUMINA INC. ( ILMN ) has 927 million in cash on hand as of last quarter
ILLUMINA INC. ( ILMN ) has 1482 million of liabilities due within 12 months, and long term debt 2239 as of last quarter
ILLUMINA INC. ( ILMN ) has 158 common shares outstanding as of last quarter
ILLUMINA INC. ( ILMN ) has 0 million USD of preferred stock value
Academic Scores:
ILLUMINA INC. ( ILMN ) Altman Z-Score is 3.10 as of last quarter
ILLUMINA INC. ( ILMN ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
ILLUMINA INC. ( ILMN ) largest shareholder is owning shares at 0.00 ($MM) value
Aimee L Hoyt(an insider) Sold 315 shares of ILLUMINA INC. ( ILMN ) for the amount of $35544.60 on 2023-11-07
0.27% of ILLUMINA INC. ( ILMN ) is held by insiders, and 93.53% is held by institutions
ILLUMINA INC. ( ILMN ) went public on 2000-07-28
Other ILLUMINA INC. ( ILMN ) financial metrics:
FCF:-182.00
Unlevered Free Cash Flow:0.00
EPS:-19.09
Operating Margin:-67.38
Gross Profit Margin:61.13
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-51.14
Beta:1.24
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About ILLUMINA INC. ( ILMN ) :
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.